ENTITY
Biogen Inc

Biogen Inc (BIIB US)

153
Analysis
Health Care • United States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
more
Exchange Announcement • 29 Jul 2026 18:36

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 29 Jul 2026 18:10

Current Report (Form 8-K | Period ending 2026-07-29)

Exchange Announcement • 02 Jul 2026 04:08

Current Report (Form 8-K | Period ending 2026-07-01)

Exchange Announcement • 11 Jun 2026 04:54

Current Report (Form 8-K | Period ending 2026-06-09)

Exchange Announcement • 11 Jun 2026 04:49

Current Report (Amendment) (Form 8-K/A | Period ending 2026-05-14)

x